Literature DB >> 24283239

Primary hyperoxaluria.

Gill Rumsby, Pierre Cochat.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24283239     DOI： 10.1056/NEJMc1311606

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  Primary and secondary hyperoxaluria: Understanding the enigma.

Authors:  Bhavna Bhasin; Hatice Melda Ürekli; Mohamed G Atta
Journal:  World J Nephrol       Date:  2015-05-06

2.  Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant.

Authors:  E C Lorenz; J C Lieske; B M Seide; A M Meek; J B Olson; E J Bergstralh; D S Milliner
Journal:  Am J Transplant       Date:  2014-05-02       Impact factor: 8.086

3.  Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I.

Authors:  Cristina Martin-Higueras; Sergio Luis-Lima; Eduardo Salido
Journal:  Mol Ther       Date:  2015-12-22       Impact factor: 11.454

4.  Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones.

Authors:  Lei He; Guofeng Xu; Xiaoliang Fang; Houwei Lin; Maosheng Xu; Yongguo Yu; Hongquan Geng
Journal:  World J Urol       Date:  2018-11-28       Impact factor: 4.226

5.  Genetic cause and prevalence of hydroxyprolinemia.

Authors:  Christian Staufner; Tobias B Haack; Patrik Feyh; Gwendolyn Gramer; Deepthi Ediga Raga; Caterina Terrile; Sven Sauer; Jürgen G Okun; Junmin Fang-Hoffmann; Ertan Mayatepek; Holger Prokisch; Georg F Hoffmann; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-05-02       Impact factor: 4.982

6.  Oxalate Formation From Glyoxal in Erythrocytes.

Authors:  John Knight; Kyle D Wood; Jessica N Lange; Dean G Assimos; Ross P Holmes
Journal:  Urology       Date:  2015-11-04       Impact factor: 2.649

7.  Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2.

Authors:  Prince Singh; Jason K Viehman; Ramila A Mehta; Andrea G Cogal; Linda Hasadsri; Devin Oglesbee; Julie B Olson; Barbara M Seide; David J Sas; Peter C Harris; John C Lieske; Dawn S Milliner
Journal:  Nephrol Dial Transplant       Date:  2022-04-25       Impact factor: 7.186

8.  Hyperoxaluria: An early diagnosis will allow a timely combined renal and liver transplantations to avoid irreversible damages to all other organs.

Authors:  Elisa Kottos; Brigitte Adams; Dominique Biarent; Xavier Beretta-Piccoli; Khalid Ismaili; David De Bels; Patrick M Honore; Sebastien Redant
Journal:  J Transl Int Med       Date:  2021-12-31

9.  Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.

Authors:  Yuhao Liu; Ying Zhao; Yousef Shukha; Haocheng Lu; Lu Wang; Zhipeng Liu; Cai Liu; Yang Zhao; Huilun Wang; Guizhen Zhao; Wenying Liang; Yanbo Fan; Lin Chang; Arif Yurdagul; Christopher B Pattillo; A Wayne Orr; Michael Aviram; Bo Wen; Minerva T Garcia-Barrio; Jifeng Zhang; Wanqing Liu; Duxin Sun; Tony Hayek; Y Eugene Chen; Oren Rom
Journal:  Cell Rep       Date:  2021-07-27       Impact factor: 9.423

10.  Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations.

Authors:  Houda Kanoun; Faiçal Jarraya; Bayen Maalej; Amina Lahiani; Hichem Mahfoudh; Fatma Makni; Jamil Hachicha; Faiza Fakhfakh
Journal:  BMC Nephrol       Date:  2017-10-02       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.